Zero Point Five Therapeutics, Inc. research brief
CIK 1985295
Generated Nov. 13, 2026, 1:34 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: BALTIMORE Maryland. Reported legal jurisdiction: DISTRICT OF COLUMBIA. These do not establish investor residence or where funds were deployed.
- April 17, 2025 · D · 0002054934-25-000002 · Source evidence
Reported offering amount: 5333250 USD. Reported amount sold: 4299420 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Zero Point Five Therapeutics, Inc. research brief,” CIK 1985295, retrieved Nov. 13, 2026, 1:34 p.m.. Cite the specific accessions used. No amounts have been summed.